Massmutual Trust CO Fsb Syndax Pharmaceuticals Inc Transaction History
Massmutual Trust CO Fsb
- $3.51 Billion
- Q4 2024
A detailed history of Massmutual Trust CO Fsb transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 65 shares of SNDX stock, worth $980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 46
41.3%
Holding current value
$980
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SNDX
# of Institutions
230Shares Held
93.3MCall Options Held
905KPut Options Held
692K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$128 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$119 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$89.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$73.6 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$63.9 Million0.01% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $853M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...